Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352)

NCT00202865 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Spondylitis, Ankylosing

Interventions

BIOLOGICAL: infliximab
BIOLOGICAL: Placebo

Sponsor

Merck Sharp & Dohme LLC